Vaccine to prevent Influenza Virus and Bacterial super-infection.

流感病毒有能力使受感染的宿主倾向于继发性细菌并发症。并发或继发细菌感染（称为超级感染）的病毒感染的死亡率通常高于单独的病毒或细菌。我们将开发一种新的多病原体候选疫苗，用于对抗主要的上呼吸道病原体-甲型流感和化脓性链球菌，以预防双重感染。

Influenza viruses have the ability to pre-dispose infected hosts toward secondary bacterial complications. The mortality of viral infections that are complicated by a concurrent, or subsequent, bacterial infection (known as a super-infection), is often greater than that of either the virus or the bacteria alone. We will develop a novel multi-pathogen vaccine candidate against the major upper respiratory tract pathogens - Influenza A and Streptococcus pyogenes to prevent super-infections.